Affordable Access

Publisher Website

A robotic BG1Luc reporter assay to detect estrogen receptor agonists

Authors
Journal
Toxicology in Vitro
0887-2333
Publisher
Elsevier
Volume
28
Issue
5
Identifiers
DOI: 10.1016/j.tiv.2014.03.013
Keywords
  • Bg1Luc
  • Bisphenol A
  • Estrogenic Activity
  • Estrogen
  • Endocrine Disruptor
  • Tritan™
Disciplines
  • Chemistry

Abstract

Abstract Endocrine disrupting chemicals with estrogenic activity (EA) have been associated with various adverse health effects. US agencies (ICCVAM/NICEATM) tasked to assess in vitro transcription activation assays to detect estrogenic receptor (ER) agonists for EA have recently validated a BG1Luc assay in manual format, but prefer robotic formats. We have developed a robotic BG1Luc EA assay to detect EA that demonstrated 100% concordance with ICCVAM meta-analyses and ICCVAM BG1Luc results in manual format for 27 ICCVAM test substances, i.e. no false negatives or false positives. This robotic assay also consistently assessed other, more problematic ICCVAM test substances such as clomiphene citrate, L-thyroxin, and tamoxifen. Agonist responses using this robotic BG1Luc assay were consistently inhibited by the ER antagonist ICI 182,780, confirming that agonist responses were due to binding to ERs rather than to a non-specific agonist response. This robotic assay also detected EA in complex mixtures of substances such as extracts of personal care products, plastic resins or plastic consumer products. This robotic BG1Luc assay had at least as high accuracy and greater sensitivity and repeatability when compared to its manual version or to the other ICCVAM/OECD validated assays for EA (manual BG1Luc and CERI).

There are no comments yet on this publication. Be the first to share your thoughts.